Skip to main content
Top
Published in: Current Cardiology Reports 7/2016

01-07-2016 | Ischemic Heart Disease (D Mukherjee, Section Editor)

Ocular Pseudoexfoliation Syndrome Linkage to Cardiovascular Disease

Authors: Juan A. Siordia, Jimena Franco, Todd R. Golden, Bilal Dar

Published in: Current Cardiology Reports | Issue 7/2016

Login to get access

Abstract

Purpose of Review

Pseudoexfoliation syndrome (PEX) is a common cause of open-angle glaucoma that is characterized by stress-induced elastic microfibrillopathy related to an accumulation of matrix metalloproteinases. The accumulation of matrix metalloproteinases increases deposition of protein substance within ocular structures and other organs including the heart. Many studies have associated the presence of cardiovascular disease with pseudoexfoliation syndrome, but much debate exists between studies in terms of significant relationships. The following meta-analysis aims to relate pseudoexfoliation syndrome with certain cardiovascular events and disorders. A thorough literature review was performed to acquire information concerning PEX patients with certain cardiovascular disorders. Diseases considered included myocardial infarction, ischemic heart disease, angina, congestive heart failure, cardiomyopathy, aortic aneurysm, hypertension, and homocystinuria. Patients without evidence of pseudoexfoliation disease were the controls of our study. Multiple forest plots were created to compile and analyze collected data for statistical comparison.

Recent Findings

From a literature review, 18 studies were selected for our analysis. Cardiovascular disorders that had a statistically significant association (within a 95 % confidence interval) with PEX included ischemic heart disease, aortic aneurysms, and homocystinuria. The association between ischemic heart disease and PEX was statistically significant (p = 0.045). Myocardial infarction, chronic ischemic heart disease, angina, and hypertension did not show a correlation of relationship with the presence of pseudoexfoliation.

Summary

Patients with PEX are prone to present with ischemic heart disease in addition to abdominal aortic aneurysms and homocystinuria. Patients that present with PEX should be screened for these detrimental cardiovascular disorders.
Literature
1.
go back to reference Anastasopoulos E, Founti P, Topouzis F. Update on pseudoexfoliation syndrome pathogenesis and associations with intraocular pressure, glaucoma and systemic diseases. Curr Opin Ophthalmol. 2015;26:82–9.CrossRefPubMed Anastasopoulos E, Founti P, Topouzis F. Update on pseudoexfoliation syndrome pathogenesis and associations with intraocular pressure, glaucoma and systemic diseases. Curr Opin Ophthalmol. 2015;26:82–9.CrossRefPubMed
2.
go back to reference Tomaszewski BT, Zalewska R, Mariak Z. Evaluation of the endothelial cell density and the central corneal thickness in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Jour Ophthalmol. 2014;2014:123683. Tomaszewski BT, Zalewska R, Mariak Z. Evaluation of the endothelial cell density and the central corneal thickness in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Jour Ophthalmol. 2014;2014:123683.
3.
go back to reference Schlotzer-Schrehardt U, von der Mark K, Sakai LY, Naumann GOH. Increased extracellular deposition of fibrillin containing fibrils in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci. 1997;38:970–84.PubMed Schlotzer-Schrehardt U, von der Mark K, Sakai LY, Naumann GOH. Increased extracellular deposition of fibrillin containing fibrils in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci. 1997;38:970–84.PubMed
4.
go back to reference Streenten BW, Li ZY, Wallace RN, Eagle Jr RC, Keshgegian AA. Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol. 1992;110:1757–62.CrossRef Streenten BW, Li ZY, Wallace RN, Eagle Jr RC, Keshgegian AA. Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol. 1992;110:1757–62.CrossRef
5.
go back to reference Schumacher S, Schlotzer-Schrehardt U, Martus P, Lang W, Naumann GOH. Pseudoexfoliation syndrome and aneurysms of the abdominal aorta. Lancet. 2001;357:359–60.CrossRefPubMed Schumacher S, Schlotzer-Schrehardt U, Martus P, Lang W, Naumann GOH. Pseudoexfoliation syndrome and aneurysms of the abdominal aorta. Lancet. 2001;357:359–60.CrossRefPubMed
6.•
go back to reference Katsi V, Pavlidis AN, Kallistratos MS, Fitsios A, Bratsas A, Tousoulis D, et al. Cardiovascular repercussions of the pseudoexfoliation syndrome. N Am J Med Sci. 2013;5:454–9. This reference contributes to a general spectrum of cardiovascular disorders to the association of PEX. It presents background information about PEX and its pathology with cardiovascular diseases. CrossRefPubMedPubMedCentral Katsi V, Pavlidis AN, Kallistratos MS, Fitsios A, Bratsas A, Tousoulis D, et al. Cardiovascular repercussions of the pseudoexfoliation syndrome. N Am J Med Sci. 2013;5:454–9. This reference contributes to a general spectrum of cardiovascular disorders to the association of PEX. It presents background information about PEX and its pathology with cardiovascular diseases. CrossRefPubMedPubMedCentral
7.
go back to reference Ringvold A, Blika S, Sandvik L. Pseudo-exfoliation and mortality. Acta Ophthalmol Scand. 1997;75:255–6.CrossRefPubMed Ringvold A, Blika S, Sandvik L. Pseudo-exfoliation and mortality. Acta Ophthalmol Scand. 1997;75:255–6.CrossRefPubMed
8.
go back to reference Shrum KR, Hattenhauer MG, Hodge D. Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol. 2000;129:83–6.CrossRefPubMed Shrum KR, Hattenhauer MG, Hodge D. Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol. 2000;129:83–6.CrossRefPubMed
9.
go back to reference Gradum K, Heijl A, Bengtssan B. Glaucoma and mortality. Graefes Arch Clin Exp Ophthalmol. 2004;242:397–401.CrossRef Gradum K, Heijl A, Bengtssan B. Glaucoma and mortality. Graefes Arch Clin Exp Ophthalmol. 2004;242:397–401.CrossRef
10.
go back to reference Ritland JS, Egge K, Lydersen S, Juul R, Semb SO. Exfoliative glaucoma and primary open-angle glaucoma: associations with death causes and comorbidity. Acta Ophthalmol Scand. 2004;82:401–4.CrossRefPubMed Ritland JS, Egge K, Lydersen S, Juul R, Semb SO. Exfoliative glaucoma and primary open-angle glaucoma: associations with death causes and comorbidity. Acta Ophthalmol Scand. 2004;82:401–4.CrossRefPubMed
11.
go back to reference Miyazaki M, Kubota T, Kubo M, Kiyohara Y, Lida M, Nose Y, et al. The prevalence of pseudoexfoliation syndrome in a Japanese population: the Hisayama study. J Glaucoma. 2005;14:482–4.CrossRefPubMed Miyazaki M, Kubota T, Kubo M, Kiyohara Y, Lida M, Nose Y, et al. The prevalence of pseudoexfoliation syndrome in a Japanese population: the Hisayama study. J Glaucoma. 2005;14:482–4.CrossRefPubMed
12.
go back to reference Brajkovic J, Kalauz-Surac I, Ercegovic A, Miletic-Huric A, Susic N, Buric Z. Ocular pseudoexfoliation syndrome and internal systemic diseases. Acta Clin Croat. 2007;46:57–61. Brajkovic J, Kalauz-Surac I, Ercegovic A, Miletic-Huric A, Susic N, Buric Z. Ocular pseudoexfoliation syndrome and internal systemic diseases. Acta Clin Croat. 2007;46:57–61.
13.
go back to reference Andrikopoulos GK, Mela EK, Georkakopoulos CD, Papadopoulos GE, Damelou AN, Alexopoulos DK, et al. Pseudoexfoliation syndrome prevalence in Greek patients with cataract and its association to glaucoma and coronary artery disease. Eye. 2009;23:442–7.CrossRefPubMed Andrikopoulos GK, Mela EK, Georkakopoulos CD, Papadopoulos GE, Damelou AN, Alexopoulos DK, et al. Pseudoexfoliation syndrome prevalence in Greek patients with cataract and its association to glaucoma and coronary artery disease. Eye. 2009;23:442–7.CrossRefPubMed
14.
go back to reference Praveen MR, Shah SK, Vasavada AR, Diwan RP, Shah SM, Zumkhawala BR, et al. Pseudoexfoliation as a risk factor for peripheral vascular disease: a case-control study. Eye (Lond). 2011;25:174–9.CrossRef Praveen MR, Shah SK, Vasavada AR, Diwan RP, Shah SM, Zumkhawala BR, et al. Pseudoexfoliation as a risk factor for peripheral vascular disease: a case-control study. Eye (Lond). 2011;25:174–9.CrossRef
15.••
go back to reference French DD, Margo CE, Harman LE. Ocular pseudoexfoliation and cardiovascular disease: a national cross section comparison study. N Am J Med Sci. 2012;4:468–73. This reference contributes to the majority of the meta-analysis and therefore delivers a significant impact between the association of PEX with cardiovascular disorders. CrossRefPubMedPubMedCentral French DD, Margo CE, Harman LE. Ocular pseudoexfoliation and cardiovascular disease: a national cross section comparison study. N Am J Med Sci. 2012;4:468–73. This reference contributes to the majority of the meta-analysis and therefore delivers a significant impact between the association of PEX with cardiovascular disorders. CrossRefPubMedPubMedCentral
16.
go back to reference Speckauskas M, Tamosiunas A, Jasinskas V. Association of ocular pseudoexfoliation syndrome with ischaemic heart disease, arterial hypertension, and diabetes mellitus. Acta Ophthalmol. 2012;90:470–5.CrossRef Speckauskas M, Tamosiunas A, Jasinskas V. Association of ocular pseudoexfoliation syndrome with ischaemic heart disease, arterial hypertension, and diabetes mellitus. Acta Ophthalmol. 2012;90:470–5.CrossRef
17.
go back to reference Tarkkanen A, Reunanen A, Kivela T. Frequency of systemic vascular disease in patients with primary open-angle glaucoma and exfoliation glaucoma. Acta Ophthalmol. 2008;86:598–602.CrossRefPubMed Tarkkanen A, Reunanen A, Kivela T. Frequency of systemic vascular disease in patients with primary open-angle glaucoma and exfoliation glaucoma. Acta Ophthalmol. 2008;86:598–602.CrossRefPubMed
18.
go back to reference Gonen KA, Gonen T, Gumus B. Renal artery stenosis and abdominal aorta aneurysm in patients with pseudoexfoliation syndrome. Eye (Lond). 2013;27:735–41.CrossRef Gonen KA, Gonen T, Gumus B. Renal artery stenosis and abdominal aorta aneurysm in patients with pseudoexfoliation syndrome. Eye (Lond). 2013;27:735–41.CrossRef
19.
go back to reference Mitchell P, Wang JJ, Smith W. Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol. 1997;124:685–7.CrossRefPubMed Mitchell P, Wang JJ, Smith W. Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol. 1997;124:685–7.CrossRefPubMed
20.
go back to reference Emiroglu MY, Coskun E, Karapinar H, Capkin M, Kaya Z, Kaya H, et al. Is pseudoexfoliation syndrome associated with coronary artery disease? N Am J Med Sci. 2010;2:487–90.CrossRefPubMedPubMedCentral Emiroglu MY, Coskun E, Karapinar H, Capkin M, Kaya Z, Kaya H, et al. Is pseudoexfoliation syndrome associated with coronary artery disease? N Am J Med Sci. 2010;2:487–90.CrossRefPubMedPubMedCentral
21.
go back to reference Jonas JB, Grundler AE. Prevalence of diabetes mellitus and arterial hypertension in primary and secondary open-angle glaucomas. Graefes Arch Clin Exp Ophthalmol. 1998;236:202–6.CrossRefPubMed Jonas JB, Grundler AE. Prevalence of diabetes mellitus and arterial hypertension in primary and secondary open-angle glaucomas. Graefes Arch Clin Exp Ophthalmol. 1998;236:202–6.CrossRefPubMed
22.
go back to reference Altintaş O, Maral H, Yüksel N, Karabaş VL, Dillioşlugil MO, Caşlar Y. Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2005;243:677–83.CrossRefPubMed Altintaş O, Maral H, Yüksel N, Karabaş VL, Dillioşlugil MO, Caşlar Y. Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2005;243:677–83.CrossRefPubMed
23.
go back to reference Citrik M, Acaroglu G, Batman C, Yildiran L, Zilelioglu O. A possible link between the pseudoexfoliation syndrome and coronary artery disease. Eye. 2007;21:11–5.CrossRef Citrik M, Acaroglu G, Batman C, Yildiran L, Zilelioglu O. A possible link between the pseudoexfoliation syndrome and coronary artery disease. Eye. 2007;21:11–5.CrossRef
24.
go back to reference Demir N, Ulus T, Yucel OE, Kumral ET, Singar E, Tanboga HI. Assessment of myocardial ischaemia using tissue Doppler imaging in pseudoexfoliation syndrome. Eye. 2011;25:1177–80.CrossRefPubMedPubMedCentral Demir N, Ulus T, Yucel OE, Kumral ET, Singar E, Tanboga HI. Assessment of myocardial ischaemia using tissue Doppler imaging in pseudoexfoliation syndrome. Eye. 2011;25:1177–80.CrossRefPubMedPubMedCentral
25.
go back to reference Ulus T, Nadir A, Yaz YA, Ozdemir AO, Mutlu F, Yazici HU, et al. Cardiovascular involvement in patients with pseudoexfoliation syndrome. J Cardiovasc Med. 2013;14:587–92.CrossRef Ulus T, Nadir A, Yaz YA, Ozdemir AO, Mutlu F, Yazici HU, et al. Cardiovascular involvement in patients with pseudoexfoliation syndrome. J Cardiovasc Med. 2013;14:587–92.CrossRef
26.
go back to reference Vessani RM, Ritch R, Liebmann JM, Jofe M. Plasma homocysteine is elevated in patients with exfoliation syndrome. Am J Ophthalmol. 2003;136:41–6.CrossRefPubMed Vessani RM, Ritch R, Liebmann JM, Jofe M. Plasma homocysteine is elevated in patients with exfoliation syndrome. Am J Ophthalmol. 2003;136:41–6.CrossRefPubMed
27.
go back to reference Naumann GOH, Schlotzer-Schrehardt U, Kuchle M. Pseudoexfoliation syndrome for the comprehensive ophthalmologist: intraocular and systemic manifestations. Ophthalmology. 1998;105:951–8.CrossRefPubMed Naumann GOH, Schlotzer-Schrehardt U, Kuchle M. Pseudoexfoliation syndrome for the comprehensive ophthalmologist: intraocular and systemic manifestations. Ophthalmology. 1998;105:951–8.CrossRefPubMed
28.
go back to reference Tetsumoto K, Schlotzer-Schrehardt U, Kuchle M, Dorfler S, Naumann GOH. Precapsular layer of the anterior lens capsule in early pseudoexfoliation syndrome. Graefes Arch Clin Exp Ophthalmol. 1992;230:252–7.CrossRefPubMed Tetsumoto K, Schlotzer-Schrehardt U, Kuchle M, Dorfler S, Naumann GOH. Precapsular layer of the anterior lens capsule in early pseudoexfoliation syndrome. Graefes Arch Clin Exp Ophthalmol. 1992;230:252–7.CrossRefPubMed
29.
go back to reference Schlotzer-Schrehardt U, Koca M, Naumann GOH, Volkholz H. Pseudoexfoliation syndrome: ocular manifestation of a systemic disorder? Arch Ophthalmol. 1992;110:1752–6.CrossRefPubMed Schlotzer-Schrehardt U, Koca M, Naumann GOH, Volkholz H. Pseudoexfoliation syndrome: ocular manifestation of a systemic disorder? Arch Ophthalmol. 1992;110:1752–6.CrossRefPubMed
30.
go back to reference Streeten BW, Dark AJ, Wallace RN, Li ZY, Hoepner JA. Pseudoexfoliation fibrillopathy in the skin of patients with ocular pseudoexfoliation. Am J Ophthalmol. 1990;110:490–9.CrossRefPubMed Streeten BW, Dark AJ, Wallace RN, Li ZY, Hoepner JA. Pseudoexfoliation fibrillopathy in the skin of patients with ocular pseudoexfoliation. Am J Ophthalmol. 1990;110:490–9.CrossRefPubMed
31.
go back to reference Eagle RC, Font RL, Fine BS. The basement membrane exfoliation syndrome. Arch Ophthalmol. 1979;97:510–5.CrossRefPubMed Eagle RC, Font RL, Fine BS. The basement membrane exfoliation syndrome. Arch Ophthalmol. 1979;97:510–5.CrossRefPubMed
32.
go back to reference Plateroti P, Plateroti AM, Abdolrahimzadeh S, Scuderi G. Pseudoexfoliation syndrome and pseudoexfoliation glaucoma: a review of the literature with updates on surgical management. J Ophthalmol 2015;2015:370371. doi:10.1155/2015/370371. Plateroti P, Plateroti AM, Abdolrahimzadeh S, Scuderi G. Pseudoexfoliation syndrome and pseudoexfoliation glaucoma: a review of the literature with updates on surgical management. J Ophthalmol 2015;2015:370371. doi:10.​1155/​2015/​370371.
33.
go back to reference Schlotzer-Schrehardt U, Kuchle M, Naumann GOH. Electron-microscopic identification of pseudoexfoliative material in extrabulbar tissue. Arch Ophthalmol. 1991;109:565–70.CrossRefPubMed Schlotzer-Schrehardt U, Kuchle M, Naumann GOH. Electron-microscopic identification of pseudoexfoliative material in extrabulbar tissue. Arch Ophthalmol. 1991;109:565–70.CrossRefPubMed
35.
go back to reference Atalar PT, Atalar E, Kilic H, Abbasoglu OE, Ozer N, Aksoyek S, et al. Impaired systemic endothelial function in patients with pseudoexfoliation syndrome. Int Heart J. 2006;47:77–84.CrossRefPubMed Atalar PT, Atalar E, Kilic H, Abbasoglu OE, Ozer N, Aksoyek S, et al. Impaired systemic endothelial function in patients with pseudoexfoliation syndrome. Int Heart J. 2006;47:77–84.CrossRefPubMed
36.
go back to reference Repo LP, Terasvirta ME, Koivisto KJ. Generalized transluminance of the iris and the frequency of pseudoexfoliation syndrome in the eyes of transient ischemic attack patients. Ophthalmology. 1993;100:353–5.CrossRef Repo LP, Terasvirta ME, Koivisto KJ. Generalized transluminance of the iris and the frequency of pseudoexfoliation syndrome in the eyes of transient ischemic attack patients. Ophthalmology. 1993;100:353–5.CrossRef
37.
go back to reference Repo LP, Suhonen MT, Terasirta ME, Koivisto KJ. Color Doppler imaging of the ophthalmic artery blood flow spectra of patients who have had a transient ischemic attack. Ophthalmology. 1995;102:1199–205.CrossRefPubMed Repo LP, Suhonen MT, Terasirta ME, Koivisto KJ. Color Doppler imaging of the ophthalmic artery blood flow spectra of patients who have had a transient ischemic attack. Ophthalmology. 1995;102:1199–205.CrossRefPubMed
39.
go back to reference Stampfer MJ, Malinow MR, Willet WC, Newcomer LM, Upson B, Ullmann D, et al. A prospective study of plasma homocysteine and risk of myocardial infarction in the US physicians. JAMA. 1992;268:877–81.CrossRefPubMed Stampfer MJ, Malinow MR, Willet WC, Newcomer LM, Upson B, Ullmann D, et al. A prospective study of plasma homocysteine and risk of myocardial infarction in the US physicians. JAMA. 1992;268:877–81.CrossRefPubMed
40.
go back to reference Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 1995;346:1395–8.CrossRefPubMed Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 1995;346:1395–8.CrossRefPubMed
41.
go back to reference Malinow MR, Nieto FJ, Szklo M. Carotid artery intimal medial wall thickening and plasma homocysteine in asymptomatic adults: the atherosclerosis risk in communities study. Circulation. 1993;87:1107–13.CrossRefPubMed Malinow MR, Nieto FJ, Szklo M. Carotid artery intimal medial wall thickening and plasma homocysteine in asymptomatic adults: the atherosclerosis risk in communities study. Circulation. 1993;87:1107–13.CrossRefPubMed
42.
go back to reference den Heijer M, Koster T, Blom HJ, Bos GMJ, Briet E, Reitsma PH, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996;334:759–62.CrossRef den Heijer M, Koster T, Blom HJ, Bos GMJ, Briet E, Reitsma PH, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996;334:759–62.CrossRef
43.
go back to reference Brunelli T, Prisco D, Fedi S, Rogolino A, Farsi A, Marcucci R, et al. High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. J Vasc Surg. 2000;32:531–6.CrossRefPubMed Brunelli T, Prisco D, Fedi S, Rogolino A, Farsi A, Marcucci R, et al. High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. J Vasc Surg. 2000;32:531–6.CrossRefPubMed
Metadata
Title
Ocular Pseudoexfoliation Syndrome Linkage to Cardiovascular Disease
Authors
Juan A. Siordia
Jimena Franco
Todd R. Golden
Bilal Dar
Publication date
01-07-2016
Publisher
Springer US
Published in
Current Cardiology Reports / Issue 7/2016
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-016-0738-5

Other articles of this Issue 7/2016

Current Cardiology Reports 7/2016 Go to the issue

Management of Acute Coronary Syndromes (AS Jaffe, Section Editor)

Spontaneous Coronary Artery Dissection

Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)

Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?

Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)

How Well Can We Control Dyslipidemias Through Lifestyle Modifications?